Privium Fund Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
294,142
+42,468
| +17% | +$97.3K | 0.15% | 42 |
|
|
2025
Q1 | $390K | Buy |
251,674
+20,000
| +9% | +$31K | 0.1% | 48 |
|
|
2024
Q4 | $544K | Buy |
231,674
+46,035
| +25% | +$108K | 0.12% | 44 |
|
|
2024
Q3 | $674K | Buy |
185,639
+25,000
| +16% | +$90.8K | 0.17% | 40 |
|
|
2024
Q2 | $543K | Buy |
160,639
+110,581
| +221% | +$374K | 0.14% | 54 |
|
|
2024
Q1 | $319K | Buy |
50,058
+15,091
| +43% | +$96.3K | 0.09% | 70 |
|
|
2023
Q4 | $239K | Hold |
34,967
| – | – | 0.07% | 68 |
|
|
2023
Q3 | $81.5K | Sell |
34,967
-32,610
| -48% | -$76K | 0.02% | 81 |
|
|
2023
Q2 | $154K | Hold |
67,577
| – | – | 0.04% | 77 |
|
|
2023
Q1 | $124K | Sell |
67,577
-45,951
| -40% | -$84.6K | 0.04% | 84 |
|
|
2022
Q4 | $205K | Hold |
113,528
| – | – | 0.08% | 68 |
|
|
2022
Q3 | $253K | Buy |
113,528
+15,000
| +15% | +$33.4K | 0.09% | 77 |
|
|
2022
Q2 | $279K | Buy |
98,528
+65,528
| +199% | +$186K | 0.09% | 79 |
|
|
2022
Q1 | $138K | Buy |
+33,000
| New | +$138K | 0.03% | 142 |
|